Isotonic NaCl solution 0.9% Eifelango Inj.-Lsg., 5x10 ml

Instructions for use for Isotonic NaCl solution 0.9% Eifelango Inj.-Lsg., 5x10 ml

Important notes (compulsory information):

Isotonic sodium chloride solution 0.9% Eifelango injection solution. Applications: As a carrier solution for electrolyte concentrates and compatible medications.

For risks and side effects, read the package leaflet and ask your doctor or pharmacist.


LEAFLET: INFORMATION FOR THE USER

Isotonic sodium chloride solution 0.9% Eifelango injection solution
Active substance: sodium chloride

Dear user, dear user!
Please read the following useful information because it contains important information about what you should consider when using this medicine. For questions, please contact your doctor or pharmacist.

Cloth or indicator group:
Carrier solution. 1 ml contains: 0.154 mmol CL and 0.154 mmol Na+.

Application areas:
As a carrier solution for electrolyte concentrates and compatible medications.

Contraindications:

• Increased sodium content of the blood (hyperremia);
• Increased chloride content of blood (hyperchloremia).

Application in pregnancy and lactation:
There are no concerns about an application during pregnancy and lactation.

Precautions for the application:
So far, no known.

Interactions with other means:
So far, no known.

Warnings:
No.

Dosage instructions, type and duration of the application:
For subcutaneous, intramuscular or intravenous injection. Dosage, type of application and application duration depend on the relevant information for the isotonic sodium chloride solution 0.9% Eifelango dissolved medicines. In the application of sodium chloride solution as a carrier solution for electrolyte concentrates, the application instructions for the encumuitant medicinal product must be observed. If you have any questions about the application, please contact your doctor or pharmacist.

Notes in the case of overdose:
The symptoms of overdose are:

• Ventilation
• increased sodium and chloride content of the blood (hyperremia, hyperchloremia)
• Hyperosmolarity
• Induction of a azidic substance change.

Therapy for overdose:
Interruption of the supply of the solution, accelerated elimination over the kidneys and a reduced supply of the corresponding electrolytes.

Side effects:
Side effects are not to be expected when used as intended.

Message of side effects:
If you notice side effects, contact your doctor or pharmacist. This also applies to side effects that are not indicated in this leaflet. You may also effect any side effects directly to the Federal Institute for Medicines and Medical Devices. Pharmacovigilance Kurt-Georg-Kiesinger Allee 3 53175 Bonn Website: www.bfarm.de. By reporting side effects, you can help to provide more information about the security of this medicine.

Notes on the durability of the medicinal product:

• You must not use the medicinal product after the expiry date specified on the folding box and the ampoule print.
• Only use clear solutions in intact containers!
• Use solution immediately after a break!
• Discard remaining stocks!
• Store drug out of reach of children!

composition
Pharmacically effective components: 1000 ml included: sodium chloride 9.00 g. Other ingredients: water for injection purposes, hydrochloric acid for pH setting Titrationacidity to pH 7.4: < 0.1 mmol / L, theoretical osmolarity: 309 MOSM / L, pH: 4.5 - 7.0.

Dosage form and content:
Injection solution in ampoules to 2 and 10 ml. Packs of 10, 50 and 100 ampoules to 2 ml. Packs of 5, 10, 50 and 100 ampoules to 10 ml.

Pharmaceutical entrepreneur and manufacturer:
Eifelango Chemisch Pharmaceutical Werk GmbH & Co. KG
Ringener Straße 45
53474 Bad Neuenahr-Ahrweiler
Telephone: 02641/36061
Fax: 02641/34056
E-Mail: [email protected]
Internet: www.eifelango.de

Status of information: July 2014.

Source: Information of the leaflet
Status: 05/2016